Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
asserted, assigned, attorney, Australian, Bisaro, British, Canadian, capacity, Centre, CGFL, children, code, consummated, copy, CPT, crosswalk, denominated, Dijon, distant, ER, Euro, Exhibit, external, fifteen, fill, franc, France, Francisco, Gateway, gBRCAm, germline, Great, Hamburg, hardware, hedging, hereto, HPH, hypothetical, III, indemnification, insight, Institut, instituted, Japanese, LeClerc, merged, merger, MolDX, patent, Paul, payable, phase, PLA, population, pound, predominantly, preliminarily, premenopausal, Procedural, prognostic, proxy, Ravgen, recurrence, recurrent, remission, retention, San, scope, Shareholder, size, software, South, study, surviving, tenant, Terminology, Trademark, upfront, vacancy, yen
Filing tables
Filing exhibits
Related press release
Associated MYGN transcripts
MYGN similar filings
Filing view
External links
Exhibit 32.1
Certification
Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
(Subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code)
Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code), each of the undersigned officers of Myriad Genetics, Inc., a Delaware corporation (the “Company”), does hereby certify, to such officer’s knowledge, that:
The Quarterly Report on Form 10-Q for the quarter ended September 30, 2022 (the “Form 10-Q”) of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, and the information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.
Date: November 2, 2022 | Date: November 2, 2022 | |||||||||||||
By: | /s/ Paul J. Diaz | By: | /s/ R. Bryan Riggsbee | |||||||||||
Paul J. Diaz | R. Bryan Riggsbee | |||||||||||||
President and Chief Executive Officer | Chief Financial Officer | |||||||||||||
Principal Executive Officer | Principal Financial and Accounting Officer |